HomeAI · summaries
Storia in 10 fonti
Bristol Myers Squibb Supercharges Drug Discovery With NVIDIA AI - Bristol-Myers Squibb (NYSE:BMY)
Bristol Myers Squibb adopts NVIDIA DGX SuperPOD to train next-gen AI models and accelerate drug discovery.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Bristol Myers to build ‘powerful’ AI factory; Samsung Biologics bids for peptide maker
Bristol Myers is the third pharmaceutical company to recently seek Nvidia’s help building a large AI data center. Elsewhere, a Novartis kidney drug gained a leg up on competitors.
- ·
statnews.com
Bristol Myers Squibb becomes latest company to claim it’s building pharma’s largest NVIDIA AI supercomputer
Bristol Myers Squibb is the third drugmaker in nine months to announce it is building the largest AI supercomputer in the life sciences industry.
